No­vo Nordisk eyes fur­ther Eu­ro­pean man­u­fac­tur­ing ex­pan­sion as it buys land in Ire­land

No­vo Nordisk is look­ing at boost­ing its man­u­fac­tur­ing foot­print in Eu­rope, with Ire­land as one of the coun­tries the phar­ma gi­ant is con­sid­er­ing, a spokesper­son told End­points News.

An 85-acre (343,983 square-me­ter) plot of land near Dublin has been ear­marked as a po­ten­tial pro­duc­tion hub for its meta­bol­ic dis­ease as­sets. “We have ac­quired land at Grange Cas­tle Busi­ness Park and have sub­mit­ted a plan­ning ap­pli­ca­tion,” the spokesper­son added in an email.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER